Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

被引：0

作者：

Younossi, Zobair ^{[1
,2
]}

Yilmaz, Yusuf ^{[1
,3
]}

Yu, Ming-Lung ^{[1
,4
,5
]}

Isakov, Vasily ^{[1
,6
]}

Fernandez, Marlen Ivon Castellanos ^{[1
,7
]}

Wong, Vincent Wai-Sun ^{[1
,8
]}

Eguchi, Yuichiro ^{[1
,9
]}

Romero-Gomez, Manuel ^{[1
,10
]}

Mendez-Sanchez, Nahum ^{[1
,11
]}

Duseja, Ajay Kumar ^{[1
,12
]}

Keklikkiran, Caglayan ^{[1
,13
]}

George, Jacob ^{[1
,14
]}

Bugianesi, Elisabetta ^{[1
,15
]}

Singal, Ashwani K. ^{[1
,16
]}

Hamid, Saeed Sadiq ^{[1
,17
]}

Alswat, Khalid A. ^{[1
,18
]}

Chan, Wah-Kheong ^{[1
,19
]}

Fan, Jiangao ^{[1
,20
]}

Papatheodoridis, George ^{[1
,21
]}

Gordon, Stuart C. ^{[1
]}

El-Kassas, Mohamed ^{[1
,23
]}

Roberts, Stuart ^{[1
,22
,24
]}

Lam, Brian ^{[1
,25
]}

Racila, Andrei ^{[26
]}

Henry, Linda ^{[1
]}

Alqahtani, Saleh ^{[1
,27
,28
]}

Stepanova, Maria ^{[1
,29
]}

机构：

[1] Global NASH Council, Washington, DC USA

[2] Beatty Liver & Obes Res Program, Falls Church, VA USA

[3] Marmara Univ, Inst Gastroenterol, Liver Res Unit, Istanbul, Turkiye

[4] Natl Sun Yat Sen Univ, Kaohsiung Med Univ Hosp, Sch Med & Doctoral Program Clin & Expt Med, Hepatobiliary Div,Dept Internal Med,Coll Med, Kaohsiung, Taiwan

[5] Natl Sun Yat Sen Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div,Dept Internal Med, Ctr Excellence Metab Associated Fatty Liver Dis, Kaohsiung, Taiwan

[6] Inst Nutr, Chief Gastroenterol & Hepatol, Moscow, Russia

[7] Univ Med Sci Havana, Inst Gastroenterol, Havana, Cuba

[8] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[9] Locomed Gen Inst, Locomed Med Cooperat, Saga, Japan

[10] Virgen Rocio Univ Hosp, Inst Biomed, Digest Dis Dept, Seville, Spain

[11] Univ Nacl Autonoma Mexico, Liver Res Unit, Med Clin & Fdn, Mexico City, DF, Mexico

[12] Postgrad Inst Med Educ & Res, Deptt Hepatol, Chandigarh, India

[13] Recap Tayyip Erdogan Univ, Sch Med, Dept Gastroenterol, Rize, Turkiye

[14] Westmead Univ Sydney, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia

[15] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy

[16] Univ Louisville, Sch Med, Louisville, KY USA

[17] Aga Khan Univ, Med Dept, Karachi, Pakistan

[18] King Saud Univ, Dept Med, Coll Med, Liver Dis Res Ctr, Riyadh, Saudi Arabia

[19] Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Fac Med, Kuala Lumpur, Malaysia

[20] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China

[21] Natl & Kapodistrian Univ Athens, Athens, Greece

[22] Henry Ford Hosp Syst, Dept Gastroenterol & Hepatol, Detroit, MI USA

[23] Helwan Univ, Endemic Med Dept, Fac Med, Cairo, Egypt

[24] The Alfred, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia

[25] Beatty Liver & Obes Res Program, Falls Church, VA USA

[26] Global Nash Council, Washington, DC USA

[27] Johns Hopkins Univ, Organ Transplant Ctr Excellence, Baltimore, MD USA

[28] King Faisal Specialist Hosp & Res Ctr, Div Gastroenterol & Hepatol, Riyadh, Saudi Arabia

[29] Ctr Outcomes Res Liver Dis, Washington, DC USA

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-438

引用

页码：S643 / S644

页数：2

共 50 条

[21] ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Nzabarushimana, Etienne
Kim, Hanseul
Jensen, Jordan
Shen, Jiaxian
Nelson, Paul
Thompson, Kelsey N.
Chan, Andrew T.
Hayete, Boris
Huttenhower, Curtis
Nguyen, Long H.
GASTROENTEROLOGY, 2024, 166 (05) : S1539 - S1540
[22] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
Eskridge, Wayne
Cryer, Donna R.
Schattenberg, Joern M.
Gastaldelli, Amalia
Malhi, Harmeet
Allen, Alina M.
Noureddin, Mazen
Sanyal, Arun J.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
[23] FATIGUE IN CHRONIC HEPATITIS B (CHB) AND C (CHC) IS ASSOCIATED WITH IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROS) AND WORK PRODUCTIVITY
Yilmaz, Yusuf
Yu, Ming-Lung
Alswat, Khalid
El-Kassas, Mohamed
Buti, Maria
Papatheodoridis, George
Castellanos Fernandez, Marlen Ivon
Eguchi, Yuichiro
Duseja, Ajay
Keklikkiran, Caglayan
Hamid, Saeed
Chan, Wah Kheong
Gordon, Stuart
Esmat, Gamal
Isakov, Vasily
Roberts, Stuart
Mendez-Sanchez, Nahum Nahum
Fan, Jian-Gao
Romero-Gomez, Manuel
George, Jacob
Singal, Ashwani
Ahmed, Aijaz
Lam, Brian
Nader, Fatema
Henry, Linda
Stepanova, Maria
Alqahtani, Saleh
HEPATOLOGY, 2024, 80 : S348 - S349
[24] Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Nabilou, Puria
Wiese, Signe
Hetland, Liv
Werge, Mikkel
Thing, Mira
Rashu, Elias
Junker, Anders
Barlose, Mads
Siebner, Hartwig
Moller, Soren
Bendtsen, Flemming
Gluud, Lise Lotte
Hove, Jens
JOURNAL OF HEPATOLOGY, 2024, 80 : S555 - S555
[25] Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Nakamura, Toru
Masuda, Atsutaka
Nakano, Dan
Amano, Keisuke
Sano, Tomoya
Nakano, Masahito
Kawaguchi, Takumi
CELLS, 2025, 14 (06)
[26] Identification of key predictors of significant weight loss in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a multicentre study
Arcari, I.
Pugliese, N.
Rocchetto, S.
Lombardi, R.
Pennisi, G.
Sagasta, M.
Soleri, M.
De Deo, D.
Cerini, F.
Cespiati, A.
De Nicola, S.
Polverini, D.
Colapietro, F.
Masetti, C.
Fracanzani, A. L.
Petta, S.
Vigano, M.
Aghemo, A.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S52 - S52
[27] Identification of key predictors of significant weight loss in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a multicentre study
Arcari, Ivan
Pugliese, Nicola
Rocchetto, Simone
Lombardi, Rosa
Pennisi, Grazia
Sagasta, Michele
Soleri, Matteo
Cerini, Federica
Cespiati, Annalisa
De Nicola, Stella
Colapietro, Francesca
Masetti, Chiara
Fracanzani, Anna
Petta, Salvatore
Vigano, Mauro
Aghemo, Alessio
JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S497
[28] IDENTIFICATION OF KEY PREDICTORS OF SIGNIFICANT WEIGHT LOSS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) PATIENTS: A MULTICENTRE STUDY
De Deo, D.
Pugliese, N.
Rocchetto, S.
Lombardi, R.
Pennisi, G.
Sagasta, M.
Arcari, I
Soleri, M.
Cerini, F.
Cespiati, A.
De Nicola, S.
Polverini, D.
Colapietro, F.
Masetti, C.
Fracanzani, A. L.
Petta, S.
Vigano, M.
Aghemo, A. M. G.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S282 - S282
[29] The rise of metabolic dysfunction-associated steatotic liver disease (MASLD) among adults in Canada between 2012 and 2018
Burnside, Jessica
Cinque, Felice
Sebastiani, Giada
Saeed, Sahar
JOURNAL OF HEPATOLOGY, 2024, 80 : S650 - S651
[30] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Ramanathan, Raghu
Patwa, Sohum A.
Ali, Ahmad Hassan
Ibdah, Jamal A.
CELLS, 2023, 12 (24)

← 1 2 3 4 5 →